US Patent Issued to Radiometer Medical on July 14 for "Determining interference criticality based on analyte and cell-free hemoglobin concentrations" (Danish Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,681,024, issued on July 14, was assigned to Radiometer Medical ApS (Bronshoj, Denmark).

"Determining interference criticality based on analyte and cell-free hemoglobin concentrations" was invented by Michael Taagaard (Bronshoj, Denmark) and Peter Frischauf (Bronshoj, Denmark).

According to the abstract* released by the U.S. Patent & Trademark Office: "There is presented an apparatus (100) for automatically measuring an analyte concentration in a liquid sample (102) comprising the analyte and cell-free hemoglobin and for automatically determining a cell-free hemoglobin interference criticality, said apparatus comprising one or more sensors (104) for measuring the analyte concentration...